Abstract

BackgroundExome sequencing using next-generation sequencing technologies is a cost efficient approach to selectively sequencing coding regions of human genome for detection of disease variants. A significant amount of DNA fragments from the capture process fall outside target regions, and sequence data for positions outside target regions have been mostly ignored after alignment.ResultWe performed whole exome sequencing on 22 subjects using Agilent SureSelect capture reagent and 6 subjects using Illumina TrueSeq capture reagent. We also downloaded sequencing data for 6 subjects from the 1000 Genomes Project Pilot 3 study. Using these data, we examined the quality of SNPs detected outside target regions by computing consistency rate with genotypes obtained from SNP chips or the Hapmap database, transition-transversion (Ti/Tv) ratio, and percentage of SNPs inside dbSNP. For all three platforms, we obtained high-quality SNPs outside target regions, and some far from target regions. In our Agilent SureSelect data, we obtained 84,049 high-quality SNPs outside target regions compared to 65,231 SNPs inside target regions (a 129% increase). For our Illumina TrueSeq data, we obtained 222,171 high-quality SNPs outside target regions compared to 95,818 SNPs inside target regions (a 232% increase). For the data from the 1000 Genomes Project, we obtained 7,139 high-quality SNPs outside target regions compared to 1,548 SNPs inside target regions (a 461% increase).ConclusionsThese results demonstrate that a significant amount of high quality genotypes outside target regions can be obtained from exome sequencing data. These data should not be ignored in genetic epidemiology studies.

Highlights

  • Exome sequencing using next-generation sequencing technologies is a cost efficient approach to selectively sequencing coding regions of human genome for detection of disease variants

  • These results demonstrate that a significant amount of high quality genotypes outside target regions can be obtained from exome sequencing data

  • These data should not be ignored in genetic epidemiology studies

Read more

Summary

Introduction

Exome sequencing using next-generation sequencing technologies is a cost efficient approach to selectively sequencing coding regions of human genome for detection of disease variants. Next-generation sequencing technologies have substantially decreased the cost of sequencing large genomic regions. It is still financially prohibitive, to perform whole genome sequencing for a large number of subjects, especially for large scale genetic epidemiology association studies, at a sufficient depth for accurate genotype calls. While exome sequencing primarily targets exons, noncoding regions such as introns, intron-exon boundary regions, UTRs, and intergenic regions can be sequenced as a byproduct. Many GWAS have established strong associations between intergenic SNPs and diseases [5-7], and many of the results have been replicated in independent datasets.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call